Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Respiratory Infections Can Trigger Heart Attacks

By HospiMedica International staff writers
Posted on 22 May 2017
A new study suggests that respiratory infections such as pneumonia, influenza, and bronchitis can increase the relative risk (RR) of acute myocardial infarction (MI) by up to 17 times.

Researchers at the University of Sydney and Royal North Shore Hospital conducted a study that included interviews with 578 patients with angiographically confirmed MI that were held within four days of hospitalization, in order to investigate the association between exposure to respiratory infection prior to the onset of MI, as compared to their usual annual frequency of these symptoms.

The results showed that symptoms of respiratory infection were reported by 17% of the patients within 7 days of MI, and by 21% within 35 days prior to MI. More...
The RR for MI within 1-7 days after respiratory infection symptoms was 17 and declined with subsequent time periods, and for those who reported milder, upper respiratory tract infection symptoms, the relative risk for the same time period was 13.5. In a sub-group analysis, RR tended to be lower in those taking regular cardiac medications. The study was published in the May 2017 issue of Internal Medicine Journal.

“Possible reasons for why respiratory infection may trigger a heart attack include an increased tendency towards blood clotting, inflammation and toxins damaging blood vessels, and changes in blood flow,” said senior author Professor Geoffrey Tofler, MD. “Our message to people is while the absolute risk that any one episode will trigger a heart attack is low, they need to be aware that a respiratory infection could lead to a coronary event. So consider preventative strategies where possible, and don't ignore symptoms that could indicate a heart attack.”

“The incidence of heart attacks is highest during winter in Australia. This winter peak is seen not only in Australia but also in other countries around the world is likely due in part to the increased incidence of respiratory infections,” added study author associate professor Thomas Buckley, RN, PhD, of the University of Sydney school of nursing. “People should take measures to reduce exposure to infection, including flu and pneumonia vaccines where appropriate.”


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.